-The Economic Times MUMBAI: India, the world's largest exporter of morphine sulphate, has very little of the drug to offer its terminally ill patients suffering from cancer and HIV. The supply of morphine, a narcotic pain reliever used for treating pain, is severely constrained in local hospitals and retail stores due to stringent laws that prevent and hinder companies from making and transporting the final product. Morphine sulphate is a byproduct of...

-The Telegraph A global effort to create a vaccine against the human immunodeficiency virus (HIV) that has abandoned dozens of candidate vaccines because of unsatisfactory trials has persuaded India to join its new vaccine-design strategy. The Translational Health Sciences and Technology Institute, a government research centre in a Haryana suburb near Delhi, will set up a laboratory for basic research to seek out molecules that can generate antibodies to effectively neutralise HIV. India’s...

-Live Mint State’s role to diminish from that of provider to manager, making way for private companies, individual practitioners The government is set to relinquish its role as a provider of primary healthcare, making way for private companies and individual medical practitioners to take the lead in offering clinical services, and focus on preventive interventions such as immunization and HIV testing. The move is in line with the government’s approach of outsourcing its...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...

Tuberculosis re-emerges as a major threat as new drug-resistant strains develop because of mismanagement of the disease. At the beginning of the year, doctors at Mumbai’s P.D. Hinduja National Hospital and Medical Research Centre reported that they had 12 patients infected with TDR-TB, or totally drug-resistant tuberculosis, a condition in which the TB bacilli is resistant to all first- and second-line drugs used in the conventional treatment of the disease. Panic...